Melanoma research
Journal
Overview
publication venue for
-
Cutaneous melanoma arising in a burn scar: two recent cases and a review of the literature.
2006
-
Assessing melanoma prognosis: the interplay between patient profiles, survival, and BRAF, NRAS, KIT, and TWT mutations in a retrospective multi-study analysis.
2024
-
Methylation of nonessential genes in cutaneous melanoma - Rule Out hypothesis..
33.
2023
-
Clinical and immune correlate results from a phase 1b study of the histone deacetylase inhibitor mocetinostat with ipilimumab and nivolumab in unresectable stage III/IV melanoma..
32.
2022
-
Uveal melanoma metastatic at initial diagnosis: a case series..
32.
2022
-
Severe blistering eruptions induced by immune checkpoint inhibitors: a multicentre international study of 32 cases..
32.
2022
-
Response to immune checkpoint inhibitor rechallenge after high-grade immune related adverse events in patients with advanced melanoma..
31.
2021
-
Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218)..
31.
2021
-
Preliminary analysis of distinct clinical and biologic features of bone metastases in melanoma..
30.
2020
-
Assessment of internet sources on subungual melanoma..
30.
2020
-
Absolute lymphocyte count as a prognostic biomarker for overall survival in patients with advanced melanoma treated with ipilimumab..
30.
2020
-
Impact of initial stage on metastatic melanoma survival..
29.
2019
-
A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanoma..
26.
2016
-
Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery..
23.
2013
-
Prognostic significance of drainage to pelvic nodes at sentinel lymph node mapping in patients with extremity melanoma..
23.
2013
-
c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potential..
22.
2012
-
Isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft-tissue sarcoma of the extremity: final report of a phase II clinical trial..
19.
2009
-
Computational model predicts effective delivery of 188-Re-labeled melanin-binding antibody to metastatic melanoma tumors with wide range of melanin concentrations..
17.
2007
-
Surgical margins in patients with cutaneous melanoma--assessing the adequacy of excision..
15.
2005
-
The association between large congenital melanocytic naevi and cutaneous melanoma: preliminary findings from an Internet-based registry of 379 patients..
15.
2005
-
Randomized, placebo-controlled pilot trial of the effects of alpha-tocopherol supplementation on levels of autoantibodies against 5-hydroxymethyl-2-deoxyuridine in melanoma patients..
14.
2004
-
Primary malignant melanoma of the oesophagus: a clinical and pathological study with emphasis on the immunophenotype of the tumours for melanocyte differentiation markers and cancer/testis antigens..
13.
2003
-
Phase I trial of high dose paracetamol and carmustine in patients with metastatic melanoma..
13.
2003
-
Use of and beliefs about dermoscopy in the management of patients with pigmented lesions: a survey of dermatology residency programmes in the United States..
12.
2002
-
Clinical results using biochemotherapy as a standard of care in advanced melanoma..
12.
2002
-
Detection of intraepidermal malignant melanoma in vivo by confocal scanning laser microscopy..
12.
2002
-
Use of and beliefs about baseline photography in the management of patients with pigmented lesions: a survey of dermatology residency programmes in the United States..
12.
2002
-
Randomized, placebo-controlled trial of dietary supplementation of alpha-tocopherol on mutagen sensitivity levels in melanoma patients: a pilot trial..
12.
2002
-
Rarity of CDK4 germline mutations in familial melanoma..
12.
2002
-
Suppression of macrophage nitric oxide production by melanoma: mediation by a melanoma-derived product..
11.
2001
-
Cytokine production by CD4+ T-cells responding to antigen presentation by melanoma cells..
9.
1999
-
Mutation and expression of the low affinity neurotrophin receptor in human malignant melanoma..
6.
1996
-
Mutation and expression of the p53 gene in human malignant melanoma..
4.
1994
-
Treatment with high dose mouse monoclonal (anti-GD3) antibody R24 in patients with metastatic melanoma..
2.
1992
-
Underreporting of acral lentiginous melanoma in studies informing American Joint Committee on Cancer Staging System Guidelines: a review of 150 cited studies.
2023
-
GNAQ and GNA11 mutations in uveal melanoma.
2014
-
Anti-melanoma effects of R24, a monoclonal antibody against GD3 ganglioside.
1997
-
Isolation limb perfusion for melanoma: current trends and future directions.
1994
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)